Dynatronics Lowered FY24 Net Sales Outlook To $32.5M-$34M (From $34M-$37M Prior), Vs Est. $34.2M

5/9/24 10:56:03 AM ET

Medical/Dental Instruments

Health Care

Get the next $DYNT alert in real time by email

The guidance cut reflects slower demand in the rehabilitation space and changes to our private label customer relationships. We are not providing gross margin guidance currently. Given our reductions in revenue expectations, we are seeking improved stabilization in the business before considering reinstituting such guidance. SG&A is anticipated to be in the range of 30% to 32% of net sales for the fiscal year.

Get the next $DYNT alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$DYNT

Date	Price Target	Rating	Analyst

More analyst ratings

$DYNT
Leadership Updates

Live Leadership Updates

Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer
Leixir Dental Laboratory Group (Leixir), a leading operator of a full-service, state-of-the-art dental laboratory network, today announced the appointment of John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier succeeds Leixir founder Harmeet Bindra, who will continue as Executive Chairman. Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries. He joins Leixir from Dynatronics Corporation (NASDAQ:DYNT), where he was most recently President and CEO. Before that, he held senior roles in corporate strategy and commercial execution, including marketing and customer experience, over seven
1/8/24 8:00:00 AM ET
$DYNT
Medical/Dental Instruments
Health Care
Appointment of Dr. Christopher von Jako as new CEO
Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company's Board of Directors has appointed Christopher von Jako, Ph.D. ("Dr. von Jako") as Chief Executive Officer and director of the Company, effective immediately. Dr. von Jako succeeds Richard Hullihen, who will be retiring and will be stepping down as a Director of the Company, effective immediately. Mr. Hullihen will assist the Company in a transitional position for the next six months. Since his appointment as CEO in 2017, Richard has overseen significant progress for Polarean. He led the Company through its successful IPO in 2018 and over $60M of ca
6/21/23 9:00:00 AM ET
$DYNT
Medical/Dental Instruments
Health Care
Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition
Consistency of Executive Leadership Expected to Provide Smooth TransitionEagan, Minnesota--(Newsfile Corp. - May 18, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that Chief Executive Officer and Director John Krier has informed the Board of his intention to resign from the company by the end of September 2023 to pursue other professional interests. Brian Baker, the company's current Chief Operating Officer, and former President and Chief Executive Officer, has accepted the role of President of Dynatronics effective immediately and will assume the titles of President, Chief Executive
5/18/23 8:05:00 AM ET
$DYNT
Medical/Dental Instruments
Health Care

$DYNT
Press Releases

Fastest customizable press release news feed in the world

Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer
Leixir Dental Laboratory Group (Leixir), a leading operator of a full-service, state-of-the-art dental laboratory network, today announced the appointment of John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier succeeds Leixir founder Harmeet Bindra, who will continue as Executive Chairman. Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries. He joins Leixir from Dynatronics Corporation (NASDAQ:DYNT), where he was most recently President and CEO. Before that, he held senior roles in corporate strategy and commercial execution, including marketing and customer experience, over seven
1/8/24 8:00:00 AM ET
$DYNT
Medical/Dental Instruments
Health Care
Appointment of Dr. Christopher von Jako as new CEO
Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company's Board of Directors has appointed Christopher von Jako, Ph.D. ("Dr. von Jako") as Chief Executive Officer and director of the Company, effective immediately. Dr. von Jako succeeds Richard Hullihen, who will be retiring and will be stepping down as a Director of the Company, effective immediately. Mr. Hullihen will assist the Company in a transitional position for the next six months. Since his appointment as CEO in 2017, Richard has overseen significant progress for Polarean. He led the Company through its successful IPO in 2018 and over $60M of ca
6/21/23 9:00:00 AM ET
$DYNT
Medical/Dental Instruments
Health Care
Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition
Consistency of Executive Leadership Expected to Provide Smooth TransitionEagan, Minnesota--(Newsfile Corp. - May 18, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that Chief Executive Officer and Director John Krier has informed the Board of his intention to resign from the company by the end of September 2023 to pursue other professional interests. Brian Baker, the company's current Chief Operating Officer, and former President and Chief Executive Officer, has accepted the role of President of Dynatronics effective immediately and will assume the titles of President, Chief Executive
5/18/23 8:05:00 AM ET
$DYNT
Medical/Dental Instruments
Health Care

Dynatronics Corporation Reports Third Quarter Fiscal Year 2023 Financial Results and Business Highlights
Eagan, Minnesota--(Newsfile Corp. - May 11, 2023) - Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its third quarter of fiscal year 2023 ended March 31, 2023, and provided an update on the business.CEO Commentary"Dynatronics experienced revenue challenges in our third fiscal quarter as a result of three external factors. As a result, we are adjusting our spending and revenue expectations as we respond to the specific impacts of:Competitive acquisitions by a significant rehabilitation customer; Reduction in specific SKUs of an OEM customer for the
5/11/23 7:00:00 AM ET
$DYNT
Medical/Dental Instruments
Health Care
Dynatronics Corporation Schedules Conference Call to Report Third Quarter Results for Fiscal 2023
Eagan, Minnesota--(Newsfile Corp. - April 27, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its third quarter of fiscal year 2023 on Thursday, May 11, 2023 before the market opens.The company will subsequently hold a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session with analysts, at 8:00 AM ET on Thursday, May 11, 2023, to review its third quarter results.Interested persons may access the live conference call by dialing 1-800-319-4610 (U.S./Canada calle
4/27/23 8:00:00 AM ET
$DYNT
Medical/Dental Instruments
Health Care
Dynatronics Corporation Reports Second Quarter Fiscal Year 2023 Financial Results and Business Highlights
EAGAN, MN / ACCESSWIRE / February 9, 2023 / Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its second quarter of fiscal year 2023 ended December 31, 2022, and provided an update on the business.CEO Commentary"The year-over-year improvement in gross margin of 8.4% or nearly $1.0 million in gross profit was a solid improvement. We are pleased with our progression, but we have more work to do. New, targeted, and innovative, product releases are the third pillar of our gross margin improvement plan, and we plan to continue to improve our performance in
2/9/23 7:30:00 AM ET
$DYNT
Medical/Dental Instruments
Health Care

$DYNT
Market Insights

Live Market Insights

Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Arhaus, Inc. (NASDAQ:ARHS) fell sharply during Monday's session. Jefferies analyst Jonathan Matuszewski downgraded Arhaus from Buy to Hold and lowered the price target from $22 to $16. Arhaus shares dipped 7.9% to $14.55 on Monday. Here are some other stocks moving in today’s mid-day session. Gainers Morphic Holding, Inc. (NASDAQ:MORF) shares jumped 75% to $55.72 after Eli Lilly agreed to buy the company for $57 per share in cash. Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) climbed 71% to $6.97 after jumping around 50% on Friday. SRIVARU Holding Limited (NASDAQ:SVMH) shares climbed 61.3% to $0.2549 after the company announced the deployment of advanced
7/8/24 1:16:55 PM ET
$ARHS
$BENF
$CJET
$CLDI
Other Specialty Stores
Consumer Discretionary
Finance: Consumer Services
Finance
This Health-Tech Stock Jumps 40% In Pre-Market A Day Ahead Of Nasdaq Delisting And Transition To OTC
In a significant development, Dynatronics Corporation (NASDAQ:DYNT) experienced a pre-market surge of 40% on Monday. This comes just a day before it transitions to the OTCQB Venture Market, following its delisting from Nasdaq. What Happened: Dynatronics’ stock was trading at $0.2982, marking a significant rise from its Friday close of $0.2120. The company, a leading manufacturer of physical therapy and rehabilitation products, is set to be delisted from Nasdaq due to its inability to meet the minimum bid price requirement. The Nasdaq delisting will come into effect at the market open on July 9. Subsequently, Dynatronics’ common stock will commence trading on the OTCQB Venture Market. T
7/8/24 7:09:04 AM ET
$DYNT
Medical/Dental Instruments
Health Care
Why Paramount Global Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Shares of Paramount Global (NASDAQ:PARAA) rose sharply in today's pre-market trading. Paramount Global and Skydance Media inked a definitive agreement to create a new entity, "New Paramount," in a $28 billion merger deal. Paramount Global shares jumped 7.5% to $22.00 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Shapeways Holdings, Inc. (NASDAQ:SHPW) rose 93.7% to $0.4068 in pre-market trading after dipping 22% on Friday. Inspire Veterinary Partners, Inc. (NASDAQ:IVP) shares rose 52.3% to $2.27 in pre-market trading after gaining 8% on Friday. Dynatronics Corporation (NASDAQ:DYNT) shares rose 36.6% to $0.29 in pre-market trading
7/8/24 5:40:41 AM ET
$AZ
$BENF
$CLEU
$DYNT
Industrial Machinery/Components
Industrials
Finance: Consumer Services
Finance

Dynatronics Lowered FY24 Net Sales Outlook To $32.5M-$34M (From $34M-$37M Prior), Vs Est. $34.2M

Chat with this insight

Recent Analyst Ratings for
$DYNT

$DYNT
Leadership Updates

Live Leadership Updates

Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

Appointment of Dr. Christopher von Jako as new CEO

Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition

$DYNT
Press Releases

Fastest customizable press release news feed in the world

Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

Appointment of Dr. Christopher von Jako as new CEO

Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition

$DYNT
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Enright Erin S. acquired 555,233 shares (SEC Form 4)

CEO & Presidentt Baker Brian D. acquired 38,942 shares, increasing direct ownership by 42% to 131,222 units (SEC Form 4)

Large owner Essig Stuart acquired 555,233 shares, increasing direct ownership by 43% to 1,547,876 units (SEC Form 4)

$DYNT
Financials

Live finance-specific insights

$DYNT
Large Ownership Changes

This live feed shows all institutional transactions in real time.

Dynatronics Corporation Reports Third Quarter Fiscal Year 2023 Financial Results and Business Highlights

Dynatronics Corporation Schedules Conference Call to Report Third Quarter Results for Fiscal 2023

Dynatronics Corporation Reports Second Quarter Fiscal Year 2023 Financial Results and Business Highlights

SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

$DYNT
Market Insights

Live Market Insights

Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session

This Health-Tech Stock Jumps 40% In Pre-Market A Day Ahead Of Nasdaq Delisting And Transition To OTC

Why Paramount Global Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

$DYNT
SEC Filings

SEC Form 10-Q filed by Dynatronics Corporation

SEC Form DEFA14A filed by Dynatronics Corporation

SEC Form DEF 14A filed by Dynatronics Corporation

Dynatronics Lowered FY24 Net Sales Outlook To $32.5M-$34M (From $34M-$37M Prior), Vs Est. $34.2M

Chat with this insight

Recent Analyst Ratings for $DYNT

$DYNT Leadership Updates

Live Leadership Updates

Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

Appointment of Dr. Christopher von Jako as new CEO

Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition

$DYNT Press Releases

Fastest customizable press release news feed in the world

Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

Appointment of Dr. Christopher von Jako as new CEO

Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition

$DYNT Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Enright Erin S. acquired 555,233 shares (SEC Form 4)

CEO & Presidentt Baker Brian D. acquired 38,942 shares, increasing direct ownership by 42% to 131,222 units (SEC Form 4)

Large owner Essig Stuart acquired 555,233 shares, increasing direct ownership by 43% to 1,547,876 units (SEC Form 4)

$DYNT Financials

Live finance-specific insights

$DYNT Large Ownership Changes

This live feed shows all institutional transactions in real time.

Dynatronics Corporation Reports Third Quarter Fiscal Year 2023 Financial Results and Business Highlights

Dynatronics Corporation Schedules Conference Call to Report Third Quarter Results for Fiscal 2023

Dynatronics Corporation Reports Second Quarter Fiscal Year 2023 Financial Results and Business Highlights

SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

$DYNT Market Insights

Live Market Insights

Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session

This Health-Tech Stock Jumps 40% In Pre-Market A Day Ahead Of Nasdaq Delisting And Transition To OTC

Why Paramount Global Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

$DYNT SEC Filings

SEC Form 10-Q filed by Dynatronics Corporation

SEC Form DEFA14A filed by Dynatronics Corporation

SEC Form DEF 14A filed by Dynatronics Corporation

Recent Analyst Ratings for
$DYNT

$DYNT
Leadership Updates

$DYNT
Press Releases

$DYNT
Insider Trading

$DYNT
Financials

$DYNT
Large Ownership Changes

$DYNT
Market Insights

$DYNT
SEC Filings